CN109125174A - 一种v脸面膜 - Google Patents
一种v脸面膜 Download PDFInfo
- Publication number
- CN109125174A CN109125174A CN201811109404.9A CN201811109404A CN109125174A CN 109125174 A CN109125174 A CN 109125174A CN 201811109404 A CN201811109404 A CN 201811109404A CN 109125174 A CN109125174 A CN 109125174A
- Authority
- CN
- China
- Prior art keywords
- extract
- face film
- facial mask
- mask essence
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 36
- 230000001815 facial effect Effects 0.000 claims abstract description 36
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 230000003266 anti-allergic effect Effects 0.000 claims abstract description 9
- 238000009418 renovation Methods 0.000 claims abstract description 9
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 7
- 244000056974 Adansonia digitata Species 0.000 claims description 11
- 235000003320 Adansonia digitata Nutrition 0.000 claims description 11
- 240000004153 Hibiscus sabdariffa Species 0.000 claims description 11
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- 235000021028 berry Nutrition 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 102000008186 Collagen Human genes 0.000 claims description 7
- 108010035532 Collagen Proteins 0.000 claims description 7
- 229920001436 collagen Polymers 0.000 claims description 7
- 244000146462 Centella asiatica Species 0.000 claims description 6
- 235000004032 Centella asiatica Nutrition 0.000 claims description 6
- 241000050051 Chelone glabra Species 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 244000042664 Matricaria chamomilla Species 0.000 claims description 6
- 235000004429 Matricaria chamomilla var recutita Nutrition 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 229940094952 green tea extract Drugs 0.000 claims description 6
- 235000020688 green tea extract Nutrition 0.000 claims description 6
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 claims description 3
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims 3
- 241000825107 Hierochloe Species 0.000 claims 2
- 235000015466 Hierochloe odorata Nutrition 0.000 claims 2
- 241000282376 Panthera tigris Species 0.000 claims 2
- 239000001331 rosmarinus officinalis leaf Substances 0.000 claims 2
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 210000001789 adipocyte Anatomy 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 230000037365 barrier function of the epidermis Effects 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 4
- 230000037303 wrinkles Effects 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 abstract description 3
- 238000000354 decomposition reaction Methods 0.000 abstract description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 2
- 108010020346 Polyglutamic Acid Proteins 0.000 abstract description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 abstract description 2
- 229960003237 betaine Drugs 0.000 abstract description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 abstract description 2
- 229920002643 polyglutamic acid Polymers 0.000 abstract description 2
- 239000011734 sodium Substances 0.000 abstract description 2
- 229910052708 sodium Inorganic materials 0.000 abstract description 2
- 229940010747 sodium hyaluronate Drugs 0.000 abstract description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 abstract description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 abstract 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 abstract 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 abstract 1
- 229920002498 Beta-glucan Polymers 0.000 abstract 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 abstract 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 abstract 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 abstract 1
- 229960000458 allantoin Drugs 0.000 abstract 1
- 229920006037 cross link polymer Polymers 0.000 abstract 1
- 229940008099 dimethicone Drugs 0.000 abstract 1
- 239000004205 dimethyl polysiloxane Substances 0.000 abstract 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 abstract 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 abstract 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 abstract 1
- 229960005323 phenoxyethanol Drugs 0.000 abstract 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 description 4
- 235000006386 Polygonum aviculare Nutrition 0.000 description 4
- 244000178231 Rosmarinus officinalis Species 0.000 description 4
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 4
- 239000004744 fabric Substances 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种V脸面膜，包括面膜精华液；所述面膜精华液包括以下成分：乙二胺四乙酸二钠、尿囊素、透明质酸钠、聚谷氨酸钠、丁二醇、甘油、甜菜碱、羟苯甲酯、羟乙基纤维素、聚二甲基硅氧烷交联聚合物、紧肤剂、抗敏修复剂、β‑葡聚糖、抗皱剂、苯氧乙醇、乙基己基甘油、纯水。本发明提供的一种V脸面膜，其通过合理设置成分及配比，可促进表皮屏障修复，并通过增加脂肪细胞的体积，促进脂肪细胞的分裂增殖，减少脂肪降解，使细胞紧致感提升，从而可提高皮肤的紧致度和丰盈度，并可提高皱纹去除效果。
Description
技术领域
本发明涉及一种V脸面膜。
背景技术
脸部肌肤的衰老常常体现在脂肪细胞的生成量的减少导致脸部部分脂肪组织流失，使得面部不再丰满，皮肤松弛下垂，V脸不再。而如何可使脸部肌肤更为紧致以重塑年轻肌肤，已成为人们日益关心的问题，虽然目前许多美容行业的企业致力于面膜的研发，但现有的面膜更侧重于对肌肤起到补水作用，但并无法提高皮肤的紧致度，从而远不能满足人们需求。
发明内容
为了克服现有技术的不足，本发明的目的在于提供一种V脸面膜，其可提高皮肤的紧致度。
本发明的目的采用以下技术方案实现：
一种V脸面膜，包括面膜精华液；所述面膜精华液包括按照重量百分比计的以下成分：
其中，该抗皱剂包括甘油、水、猴面包树果提取物、玫瑰茄花提取物。
所述抗皱剂中的甘油、水、猴面包树果提取物、玫瑰茄花提取物的重量比为5：3：1：1。
所述抗敏修复剂包括水、丁二醇、光果甘草根提取物、绿茶提取物、迷迭香叶提取物、积雪草提取物、母菊花提取物、黄芩提取物、虎杖提取物。
所述抗敏修复剂中的水、丁二醇、光果甘草根提取物、绿茶提取物、迷迭香叶提取物、积雪草提取物、母菊花提取物、黄芩提取物、虎杖提取物的重量比为38:50:1:1:0.5:5:0.5:2:2。
所述面膜精华液还包括香精、增溶剂，所述香精的重量百分比为0.01-0.03％；增溶剂的重量百分比为0.05-0.1％。
所述增溶剂包括PEG-50氢化蓖麻油、壬基酚聚醚-14、丙二醇和水。
紧肤剂包括葡糖氨基葡聚糖和水解胶原蛋白；紧肤剂中的葡糖氨基葡聚糖、水解胶原蛋白的重量比为2:3。
所述面膜精华液包括按照重量百分比计的以下成分：
所述面膜精华液包括按照重量百分比计的以下成分：
所述面膜精华液包括按照重量百分比计的以下成分：
相比现有技术，本发明的有益效果在于：本发明提供的一种V脸面膜，其通过合理设置成分及配比，可促进表皮屏障修复，并通过增加脂肪细胞的体积，促进脂肪细胞的分裂增殖，减少脂肪降解，使细胞紧致感提升，从而可提高皮肤的紧致度和丰盈度，并可提高皱纹去除效果。
具体实施方式
下面，结合具体实施方式，对本发明做进一步描述，需要说明的是，在不相冲突的前提下，以下描述的各实施例之间或各技术特征之间可以任意组合形成新的实施例。
一种V脸面膜，包括面膜精华液；所述面膜精华液包括按照重量百分比计的以下成分：
其中，该抗皱剂包括甘油、水、猴面包树果提取物、玫瑰茄花提取物。
本发明提供的一种V脸面膜，其通过利用透明质酸钠、聚谷氨酸钠、甜菜碱、β-葡聚糖，可给肌肤补充水分，让皮肤喝饱水，从而可促进后续营养成分的吸收，而通过利用抗皱剂中的甘油、猴面包树果提取物和玫瑰茄花提取物的相互协同作用，可为肌肤提供较高的抗氧化成分、丰富的矿物质和微量元素，具有良好的保湿作用，并可起到较强的抗氧化作用，增加皮肤弹性，并通过增加脂肪细胞的体积，促进脂肪细胞的分裂增殖，减少脂肪降解，使细胞紧致感提升，从而可提高皮肤的紧致度和丰盈度，以使脸部可保持“V”形，并可提高皱纹去除效果；同时，还可通过利用抗敏修复剂，促进表皮屏障修复，抵抗刺激，提高安全性。
所述面膜精华液还包括香精、增溶剂，所述香精的重量百分比为0.01-0.03％；增溶剂的重量百分比为0.05-0.1％。
所述抗皱剂中的甘油、水、猴面包树果提取物、玫瑰茄花提取物的重量比为5：3：1：1。而通过优化抗皱剂中的甘油、水、猴面包树果提取物、玫瑰茄花提取物的配比，从而可提高皮肤的紧致度和丰盈度的情况下，并可有效控制成本。
所述抗敏修复剂包括水、丁二醇、光果甘草根提取物、绿茶提取物、迷迭香叶提取物、积雪草提取物、母菊花提取物、黄芩提取物、虎杖提取物，从而可进一步提高其抗过敏性能，进一步促进表皮屏障的修复。
所述抗敏修复剂中的水、丁二醇、光果甘草根提取物、绿茶提取物、迷迭香叶提取物、积雪草提取物、母菊花提取物、黄芩提取物、虎杖提取物的重量比为38:50:1:1:0.5:5:0.5:2:2。而通过优化抗敏修复剂中的各成分的配比，可在提高其抗过敏性能促进表皮屏障的修复的同时，并可有效控制成本。
其中，本发明V脸面膜的增溶剂可采用市面上现有的任意一种增溶剂，只要可增加香精的溶解度即可，例如，所述增溶剂可包括PEG-50氢化蓖麻油、壬基酚聚醚-14、丙二醇和水。
紧肤剂包括葡糖氨基葡聚糖和水解胶原蛋白，从而可为皮肤提供胶原蛋白，并使皮肤更易于吸收，从而可使皮肤更为紧致；紧肤剂中的葡糖氨基葡聚糖、水解胶原蛋白的重量比为2:3。
而在使用过程中，可将V脸面膜的面膜精华液直接涂抹于脸部上。而优选的，该V脸面膜还包括用于浸泡于面膜精华液中的面膜布，而在使用时，可将面膜布浸泡于面膜精华液中，然后将浸泡有面膜精华液的面膜布敷于面上，从而可提高使用效果。
实施例1
本实施例的一种V脸面膜，包括面膜精华液；所述面膜精华液包括按照重量百分比计的以下成分：
其中，该抗皱剂包括甘油、水、猴面包树果提取物、玫瑰茄花提取物。
实施例2
本实施例的一种V脸面膜，包括面膜精华液；所述面膜精华液包括按照重量百分比计的以下成分：
其中，该抗皱剂包括甘油、水、猴面包树果提取物、玫瑰茄花提取物。
实施例3
本实施例的一种V脸面膜，包括面膜精华液；所述面膜精华液包括按照重量百分比计的以下成分：
其中，该抗皱剂包括甘油、水、猴面包树果提取物、玫瑰茄花提取物。
效果评价及性能测试
1.安全测试
将实施例1-3的V脸面膜分别分给100名测试人员，各实施例的V脸面膜均采用以下的方式进行测试，测试人员以左右手臂内侧做对照测试，在左手内侧每次涂该V脸面膜的面膜精华液0.5g，并记录24h、72h后的皮肤反应现象。若出现发红、红斑、瘙痒、起疹现象均为过敏。而使用实施例1-3的V脸面膜，并没有测试人员出现过敏现象，结果表明：涂本发明产品24h、72h后，未见皮肤发红或出现红斑等过敏现象，说明本发明的该V脸面膜是安全的，没有任何不良现象。
2.功能型效果测试：
选取三组测试人员，每组具有25名女性测试者，年龄分布为31-65岁，将
实施例1-3的该V脸面膜分别对应地分给三组测试人员使用，连续使用四周，每周使用两次。而根据测试结果可知：80％的测试人员的皱纹减少，丰盈度、紧致度及水合效果均大大增加，使脸部肌肤提拉紧致。
上述实施方式仅为本发明的优选实施方式，不能以此来限定本发明保护的范围，本领域的技术人员在本发明的基础上所做的任何非实质性的变化及替换均属于本发明所要求保护的范围。
Claims (10)
1.一种V脸面膜，其特征在于：包括面膜精华液；所述面膜精华液包括按照重量百分比计的以下成分：
其中，该抗皱剂包括甘油、水、猴面包树果提取物、玫瑰茄花提取物。
2.如权利要求1所述的V脸面膜，其特征在于：所述抗皱剂中的甘油、水、猴面包树果提取物、玫瑰茄花提取物的重量比为5：3：1：1。
3.如权利要求1所述的V脸面膜，其特征在于：所述抗敏修复剂包括水、丁二醇、光果甘草根提取物、绿茶提取物、迷迭香叶提取物、积雪草提取物、母菊花提取物、黄芩提取物、虎杖提取物。
4.如权利要求3所述的V脸面膜，其特征在于：所述抗敏修复剂中的水、丁二醇、光果甘草根提取物、绿茶提取物、迷迭香叶提取物、积雪草提取物、母菊花提取物、黄芩提取物、虎杖提取物的重量比为38:50:1:1:0.5:5:0.5:2:2。
5.如权利要求1所述的V脸面膜，其特征在于：所述面膜精华液还包括香精、增溶剂，所述香精的重量百分比为0.01-0.03％；增溶剂的重量百分比为0.05-0.1％。
6.如权利要求5所述的V脸面膜，其特征在于：所述增溶剂包括PEG-50氢化蓖麻油、壬基酚聚醚-14、丙二醇和水。
7.如权利要求1所述的V脸面膜，其特征在于：紧肤剂包括葡糖氨基葡聚糖和水解胶原蛋白；紧肤剂中的葡糖氨基葡聚糖、水解胶原蛋白的重量比为2:3。
8.如权利要求1所述的V脸面膜，其特征在于：所述面膜精华液包括按照重量百分比计的以下成分：
9.如权利要求1所述的V脸面膜，其特征在于：所述面膜精华液包括按照重量百分比计的以下成分：
10.如权利要求1所述的V脸面膜，其特征在于：所述面膜精华液包括按照重量百分比计的以下成分：
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811109404.9A CN109125174A (zh) | 2018-09-21 | 2018-09-21 | 一种v脸面膜 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811109404.9A CN109125174A (zh) | 2018-09-21 | 2018-09-21 | 一种v脸面膜 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109125174A true CN109125174A (zh) | 2019-01-04 |
Family
ID=64823190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811109404.9A Pending CN109125174A (zh) | 2018-09-21 | 2018-09-21 | 一种v脸面膜 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109125174A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019098819A3 (es) * | 2017-11-16 | 2019-08-08 | Olvera Villa Ricardo | Proceso para la elaboración de mascarillas para el cuidado de la piel, usando como material base polímeros parcialmente reticulados y un método para reticularlos parcialmente |
| CN110464690A (zh) * | 2019-09-24 | 2019-11-19 | 武汉兆京生物科技有限公司 | 一种v脸塑形的组合物 |
| CN111617002A (zh) * | 2020-06-24 | 2020-09-04 | 玮格沃德贸易有限公司 | 一种补水提亮紧致面膜 |
| CN113288849A (zh) * | 2021-06-30 | 2021-08-24 | 范祖强 | 一种面膜及其制备方法和应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105342904A (zh) * | 2015-11-02 | 2016-02-24 | 嘉文丽（福建）化妆品有限公司 | 一种具有皮肤抗皱功效的精华液 |
| CN106726872A (zh) * | 2016-11-21 | 2017-05-31 | 日昇昌科技有限公司 | 一种猴面包果植物精粹面膜及其制备方法 |
-
2018
- 2018-09-21 CN CN201811109404.9A patent/CN109125174A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105342904A (zh) * | 2015-11-02 | 2016-02-24 | 嘉文丽（福建）化妆品有限公司 | 一种具有皮肤抗皱功效的精华液 |
| CN106726872A (zh) * | 2016-11-21 | 2017-05-31 | 日昇昌科技有限公司 | 一种猴面包果植物精粹面膜及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 广东思埠基团有限公司: "天使之魅蓝莓面膜", 《国产非特殊用途化妆品备案信息服务平台》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019098819A3 (es) * | 2017-11-16 | 2019-08-08 | Olvera Villa Ricardo | Proceso para la elaboración de mascarillas para el cuidado de la piel, usando como material base polímeros parcialmente reticulados y un método para reticularlos parcialmente |
| CN110464690A (zh) * | 2019-09-24 | 2019-11-19 | 武汉兆京生物科技有限公司 | 一种v脸塑形的组合物 |
| CN111617002A (zh) * | 2020-06-24 | 2020-09-04 | 玮格沃德贸易有限公司 | 一种补水提亮紧致面膜 |
| CN113288849A (zh) * | 2021-06-30 | 2021-08-24 | 范祖强 | 一种面膜及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109125174A (zh) | 一种v脸面膜 | |
| CN105125476B (zh) | 一种抗皱精华液及其制备方法 | |
| CN110200875B (zh) | 一种抗敏美白面膜及其制备方法 | |
| CN111658818B (zh) | 一种医用修复敷料及其应用 | |
| CN105168112B (zh) | 一种抗皱爽肤水及其制备方法 | |
| CN109106664A (zh) | 具有保湿舒缓修护功效的组合物、面膜及其制备方法 | |
| CN104173232A (zh) | 一种提升肌肤抵抗力并修复微损肌肤的美容液制作方法 | |
| CN108670901B (zh) | 一种以澳洲坚果蛋白肽和青皮提取液为活性成分的柔肤水及其制备方法 | |
| CN109662924A (zh) | 一种无刺激补水修复面膜及其制备方法 | |
| CN112043619B (zh) | 一种具有修复作用的肽类组合物及其制备方法和应用 | |
| CN104069036A (zh) | 抗衰老化妆品组合物及其制备方法 | |
| CN110559247A (zh) | 一种多肽植物天然面膜及应用 | |
| CN104490713A (zh) | 一种具有排浊紧致和抗皱活化肌肤功能的超软活泉护肤品 | |
| CN106309260B (zh) | 一种三七驻颜面膜 | |
| CN107753357A (zh) | 一种含干细胞分泌因子的化妆水 | |
| CN111434332A (zh) | 滋养修护乳液及其制备方法 | |
| CN106309196A (zh) | 一种天然活肤精华及其制备方法 | |
| CN107982097A (zh) | 一种含干细胞分泌因子的面霜 | |
| CN111450017A (zh) | 一种含富勒烯的美容精华液及其制备方法 | |
| CN112402308A (zh) | 一种多效舒缓保湿水及其制备方法 | |
| CN108815002B (zh) | 一种含有水溶性神经酰胺的护肤品和护发品 | |
| CN108992364B (zh) | 一种含有月桂酰谷氨酸钠的保湿洗面奶 | |
| KR20110052095A (ko) | 흰목이 버섯 추출물을 함유하는 피부 보습용 화장료 조성물 | |
| CN108836904A (zh) | 一种祛除皱纹的护肤组合物及其制备方法与应用 | |
| CN113116765B (zh) | 精华原液及其制备方法和胶原酶抑制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190104 |